Withings

🏥 Withings has officially launched a Medical Group 🏥 And we are already taking care of our first patients. Reflecting on my 11 years at Withings, this milestone feels incredibly special. Seeing our long-time device users choose to trust us with their clinical care is deeply humbling, and it feels like the missing piece. The real catalyst was the US government's new CMS ACCESS model, which rewards organizations like Withings for improving health outcomes for patients with chronic conditions, all at $0 out-of-pocket costs for the patients. It is an approach we hope will also inspire the French government, as it has the immense potential to both improve care and reduce systemic costs. While our vision heavily leverages Withings' latest hardware, biomarkers and AI behind the scenes, we are keeping our care team and the patient firmly at the center. Empowered by technology, our clinicians use continuous, hospital-grade data from our devices, alongside coordinated labs, personalized prescriptions, virtual visits, and tailored educational content to catch health issues early. To power this seamlessly, our new infrastructure integrates a modern EMR, coupled with Withings Remote Monitoring platform and a modern AI stack. By vastly reducing administrative friction, we maximize our care team's efficiency so they can focus entirely on medicine, while creating an effortless experience for patients. Let's continue this journey together Younes Brini, François Force, Patrick Sheehan, Nisha Basu, Mikela Yarawamai, MD cc Eric Carreel To learn more about this new initiative: https://lnkd.in/e5FkDuVu

Lorsque j'ai rencontré Marie Pirotais et son co-fondateur Yann Le Guillou, j'ai reconnu en eux l'ADN Withings : des personnalités passionnées, scientifiquement rigoureuses, animées par la volonté de disrupter le système de santé pour l'améliorer. Deux fondateurs, deux parcours, une même conviction. Marie a co-fondé Biosency avec une ambition : détecter tôt les signes d'aggravation chez les patients insuffisants respiratoires, avant l'urgence. Chez Withings, depuis 2009, nous poursuivons la même intuition sur la santé du quotidien : votre corps vous parle, encore faut-il pouvoir l'entendre. Avec Biosency, Marie a développé une approche profondément médicale et clinique ; chez Withings, du quotidien des foyers. Le même problème, abordés par deux approches complémentaires, guidées par la même conviction. Aujourd'hui, ces deux chemins se rejoignent. Et ce que je retiens de cette rencontre, ce n'est pas une opération, c'est un alignement rare entre l'exigence clinique et une conviction que nous partageons depuis le premier jour : détecter tôt change tout. Bienvenue Marie, bienvenue à l'équipe Biosency.

We are proud to collaborate with Samsung Electronics to expand choices for consumers. At Withings, we believe that putting the user first means offering the flexibility to use the health tools that best fit your lifestyle. Through July 19, 2026, receive a complimentary Withings Body Smart scale ($129.95 value) with the purchase of an eligible Galaxy Watch on Samsung.com (US only). Enjoy your Galaxy Watch. We hear it pairs beautifully with a Withings scale. Learn more: https://lnkd.in/enFcz2-R

🇫🇷📈 We're proud to share that Withings reached full-year profitability in 2025, closing an eight-year chapter, eighteen years after our founding. Since buying back the company from Nokia in 2018, we’ve grown global revenue by ~90%, with the United States now standing as our #1 market worldwide. What makes this milestone unique? It’s the rare combination of scale, clinical credibility, and profitability in connected health: • Scale & clinical validation: 66% of total 2025 revenue came from FDA-cleared medical devices. • Engagement & data footprint: Across 10 million active devices worldwide, we recorded over 1 billion health measurements in 2025 (more than a third of them clinical grade). • B2B velocity: Withings Health Solutions has scaled patient enrollment in remote monitoring from 25,500 before the buyback to more than 740,000 today across the U.S. and Europe. This reflects a conviction we've held from day one: that connected health would eventually shift from consumer gadgetry to true clinical-grade prevention. Achieving this required deep, disciplined reinvestment. We've funneled 20% to 27% of annual revenue into R&D every single year since the buyback—close to double the consumer electronics norm. That commitment produced a record 31 clinical studies in 2025 alone and 150 published clinical articles to date. 🗣 "Longevity, prevention, and at-home monitoring have moved from niche to mainstream, and Withings has been building for this exact moment for eighteen years." — Eric Carreel, Chairman & Co-founder As a company built in France, reaching this milestone with the U.S. as our largest market means everything. And we're just getting started. Read the full article here: https://lnkd.in/eWEDC55X

Diagnosis of obstructive sleep apnea (OSA) still relies primarily on a single night of testing, despite the condition affecting an estimated one billion adults worldwide. New peer-reviewed research led by Flinders Health and Medical Research Institute Sleep Health, found that multi-night monitoring with Sleep Analyzer achieved 86% sensitivity and 90% specificity for detecting moderate-to-severe OSA compared with in-home polysomnography. In 10 of 45 participants diagnosed with moderate-to-severe OSA, multi-night monitoring surfaced additional information that may have changed the clinical diagnosis. Participants also recorded a median of 80 nights of monitoring across three months. Lead author Dr. Bastien Lechat said the findings highlight an important limitation of current diagnostic approaches. "Sleep apnea can vary considerably from one night to the next, so if you only measure it once, you may not capture the true severity of the condition." Read the full study: https://lnkd.in/gZV9brT3 

☀️🌡️ Our latest data from the current European heatwave reveals a massive impact on our health: ✔ Sleep Loss: Europeans lost a median of -33 min/night. On the worst night (June 23), this skyrocketed to -51 min in France and -44 min in the UK. ✔ Activity Drop: Energy levels plummeted with a median drop of -851 steps/day. ✔ Physical Stress: Nightly respiratory rates spiked by a median of +0.24 bpm, showing how hard the body works to stay cool. 🇫🇷 France took the heaviest hit, suffering a median drop of -40 min/night of sleep and -982 steps/day. How has the heatwave affected your sleep? Let us know below. — 🔒 This study was conducted by Withings based on data gathered from a panel of Withings users. Withings guarantees the confidentiality of personal data and protects the privacy of all its users. Therefore, all data used for this study was rigorously anonymized and aggregated in order to avoid any re-identification.

Today, Withings is taking an important step forward with the acquisition of Biosency. This Rennes-based team has spent years working on a problem that truly matters: detecting a respiratory exacerbation before it leads to hospitalization. Their medically certified algorithm identifies early signs of decompensation in COPD patients, early enough for caregivers and patients to act. This is exactly what we set out to build: moving health monitoring from observation to anticipation. With Biosency, Withings enters respiratory remote monitoring and advances its ambition: to build a strong, independent European player supporting the transformation of healthcare systems. A warm welcome to the entire Biosency team 👋 Read the full article here: https://lnkd.in/eWEDC55X

Touchdown in Paris at #VivaTech 2026 🇫🇷
 Have a question about the future of science-backed longevity? Come meet our teams. From today through June 20, Withings joins the 10th edition of Europe's biggest tech event, at Paris Expo Porte de Versailles. ➜ Be among the first to experience our freshly launched BodyScan 2, alongside the full Withings ecosystem. 📆 June 17–20, 2026 ⏰ 9am – 6pm 📍 Hall 7.1 — Booth A11 · Paris Expo Porte de Versailles Will we see you there? Discover BodyScan 2: https://lnkd.in/eSeiJUJS

One room. Zero holding back. We brought the Withings community to Tone House ® NYC to sweat, push, and celebrate the launch of #BodyFit. Heart rates spiking, bodies moving and everyone giving everything they had. Because BodyFit goes deeper than the surface — it tracks the body composition data that shows you what real effort does to your body. This community showed up and proved exactly why we built BodyFit. The energy in that room? Unmatched. 🔥

“It’s really an opportunity to use that one-minute step-on to deep-dive into all your organs.” 👀🫀🫁 What makes BodyScan 2¹ the most advanced longevity station yet? Watch as our Director of Research, Bruno Carreel, breaks down our groundbreaking innovation in 60 seconds. Discover BodyScan 2: https://lnkd.in/eSeiJUJS #Longevity #BodyScan2 ¹BodyScan 2 is now available across Europe and will be available in the US 🇺🇸 next week, on June 16.